BMI1 and cholangiocarcinoma: Additionally, as was previously referred to, EV-BMI1 in CCA tissues/cells, promote CCA growth and progression, whereas BMI1 knockdown can lead to tumor growth suppression, via enhancing the anti-tumor immunity towards CCA cells and the immune checkpoint inhibition [79].